MiMedx® Group Announces Positive Results From Diabetic Foot Ulcer Randomized Controlled Trial
11:26 EDT 7 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
KENNESAW, Ga., Aug. 7, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced ...
Other Sources for this Article
More From BioPortfolio on "MiMedx® Group Announces Positive Results From Diabetic Foot Ulcer Randomized Controlled Trial"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
